eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   o   Check drugs   o   Compare drugs   o   Report a side effect
Join a support group   o   Ask a question   o   Write a review   o   Answered/ Unanswered   o   Reviews

Review: taking Coumadin and Norvasc together

Summary: drug interactions are reported among people who take Coumadin and Norvasc together.

This review analyzes the effectiveness and drug interactions between Coumadin and Norvasc. It is created by eHealthMe based on reports of 6,855 people who take the same drugs from FDA and social media, and is updated regularly.

 

You are not alone: join a support group for people who take Coumadin and Norvasc >>>

On Feb, 27, 2015: 6,855 people who take Coumadin, Norvasc are studied

Coumadin, Norvasc outcomes

Drug combinations in study:
- Coumadin (warfarin sodium)
- Norvasc (amlodipine besylate)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Coumadin is effective25.00%
(2 of 8 people)
50.00%
(8 of 16 people)
66.67%
(4 of 6 people)
66.67%
(8 of 12 people)
76.47%
(13 of 17 people)
58.33%
(7 of 12 people)
93.33%
(14 of 15 people)
100.00%
(1 of 1 people)
Norvasc is effective0.00%
(0 of 3 people)
23.08%
(3 of 13 people)
33.33%
(2 of 6 people)
22.22%
(4 of 18 people)
59.09%
(13 of 22 people)
58.82%
(10 of 17 people)
63.64%
(7 of 11 people)
0.00%
(0 of 1 people)

Drug effectiveness by gender :

FemaleMale
Coumadin is effective50.00%
(17 of 34 people)
75.47%
(40 of 53 people)
Norvasc is effective40.00%
(14 of 35 people)
44.64%
(25 of 56 people)

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Coumadin is effectiven/an/an/an/an/a30.00%
(3 of 10 people)
54.17%
(13 of 24 people)
40.20%
(41 of 102 people)
Norvasc is effectiven/an/an/an/an/a10.00%
(1 of 10 people)
23.81%
(5 of 21 people)
28.95%
(33 of 114 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
International Normalised Ratio IncreasedDyspnoeaDyspnoeaNephrogenic Systemic FibrosisDyspnoeaPainInternational Normalised Ratio IncreasedPain
DyspnoeaOedema PeripheralDizzinessAnxietyDeep Vein ThrombosisAnxietyHaemoglobin DecreasedOedema Peripheral
Gastrointestinal HaemorrhageCardiac Failure CongestiveRenal Failure AcuteSyncopeInternational Normalised Ratio IncreasedGeneral Physical Health DeteriorationGingival BleedingDyspnoea
Renal Failure AcuteMyocardial InfarctionFallOedema PeripheralAnxietyNephrogenic Systemic FibrosisOccult Blood PositiveAtrial Fibrillation
Haemoglobin DecreasedAnxietyAtrial FibrillationRhabdomyolysisPulmonary HaemorrhageMobility DecreasedDizzinessAnxiety
Renal FailureTransient Ischaemic AttackBradycardiaHepatic Function AbnormalCirculatory CollapseRashUpper Gastrointestinal HaemorrhageInternational Normalised Ratio Increased
BradycardiaCellulitisIntervertebral Disc DisplacementHypoaesthesiaCardiac FailureMajor DepressionCoagulopathyNausea
OedemaIntracranial AneurysmEar DisorderDisseminated Intravascular CoagulationPneumoniaSkin DisorderGastric CancerAsthenia
HypokalaemiaChest PainFlushingAstheniaSyncopeDiscomfortMelaenaFatigue
Drug Effect IncreasedLacunar InfarctionGroin PainPainAnaemiaEmotional DistressAbdominal Pain UpperCardiac Failure Congestive

Most common drug interactions by gender * :

FemaleMale
PainPain
AstheniaDyspnoea
NauseaOedema Peripheral
Atrial FibrillationCardiac Failure Congestive
Oedema PeripheralInternational Normalised Ratio Increased
AnxietyAnxiety
International Normalised Ratio IncreasedAtrial Fibrillation
DyspnoeaNausea
FallAsthenia
FatigueFatigue

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
Pleural EffusionHallucination, VisualSubdural HaematomaPainPainOedema PeripheralPainAtrial Fibrillation
Hepatic Function AbnormalRoad Traffic AccidentSyncopeNephrogenic Systemic FibrosisNephrogenic Systemic FibrosisInternational Normalised Ratio IncreasedAnxietyInternational Normalised Ratio Increased
Disseminated Intravascular CoagulationSleep DisorderLower Gastrointestinal HaemorrhageSkin TightnessAnxietyDyspnoeaOedema PeripheralPain
RhabdomyolysisTachycardiaVaricellaOedema PeripheralSkin IndurationErythemaNauseaAsthenia
PyrexiaFeeling AbnormalDiarrhoeaMobility DecreasedSkin TightnessPainDepressionDyspnoea
PneumoniaTremorBack PainOedemaFibrosisNephrogenic Systemic FibrosisDyspnoeaNausea
Pulmonary HypertensionConfusional StateSkull FractureSkin HyperpigmentationRenal FailureCellulitisNephrogenic Systemic FibrosisOedema Peripheral
AnaemiaFallContusionSkin DisorderSkin HypertrophyArthralgiaPain In ExtremityCardiac Failure Congestive
Abortion Spontaneous NosConstipationArthralgiaSkin DepigmentationEmotional DistressFatigueAnaemiaAnaemia
Paternal Drugs Affecting FoetusContusionPeroneal Nerve PalsyChest PainPain In ExtremityMuscular WeaknessFatigue

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of Coumadin and Norvasc on

Do you take Coumadin and Norvasc?

 

 

 

You are not alone! Join a related support group:
- support group for people who take Coumadin
- support group for people who take Norvasc

Recent related drug studies (Check your drugs):

Complete drug side effects:

On eHealthMe, Coumadin (warfarin sodium) is often used to treat blood clots. Norvasc (amlodipine besylate) is often used to treat high blood pressure. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.